IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Biomark Capital Management Co. LLC

Q3 2018 Holdings

Filed 2018-10-24 | 2 holdings | $8.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adma Biologics, Inc.(ADMA)COM000899104$8.9M1,433,304100.0%
Mabvax Therapeutics Holdings, Inc.COM PAR55414P702$48,9030.0%